Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,785 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,785 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,785 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,785 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,785 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,785 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,785 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
Rhonda Farnum SVP, Comm & Medical Affairs
Sold on a plan 3×
$433.64K 31,067 at 13.96
11.8%
Planned (10b5-1)
16 Mar 2026
Johanna Mercier Chief Comm & Corp Aff Officer
Sold on a plan
$432.69K 3,000 at 144.23
2.2%
Planned (10b5-1)
16 Mar 2026
Mittie Doyle Chief Medical Officer
Sold on a plan
$411.61K 25,492 at 16.15
87.6%
Sold half or more
16 Mar 2026
Shannon Lucas President & COO · indirect
Sold on a plan
$407.93K 22,500 at 18.13
1.4%
Planned (10b5-1)
16 Mar 2026
Javier Olivan Chief Operating Officer · indirect
Sold on a plan 4×
$397.54K 629 at 632.02
18.8%
Planned (10b5-1)
16 Mar 2026
Stephen F. Betz Chief Scientific Officer
Sold on a plan 2×
$396.61K 10,612 at 37.37
7.2%
Planned (10b5-1)
16 Mar 2026
David McGlinchey Chief Development Officer
Sold at will
$393.77K 4,872 at 80.82
9.1%
Not planned
16 Mar 2026
Brandon F. Lombardi Chief Legal Officer
Sold at will
$393.69K 4,871 at 80.82
19.6%
Not planned
16 Mar 2026
Shawn David Flores See Remarks
Sold at will
$387.30K 7,167 at 54.04
16.5%
Not planned
16 Mar 2026
Jeff E. Knight Chief Operating Officer
Sold on a plan 2×
$370.41K 9,911 at 37.37
8.1%
Planned (10b5-1)
16 Mar 2026
Lisa Blackwood-Kapral Chief Accounting Officer
Sold on a plan
$363.80K 9,390 at 38.74
16.5%
Planned (10b5-1)
16 Mar 2026
Christopher W Pyne EVP, Group Benefits
Sold at will
$351.62K 4,852 at 72.47
8.5%
Not planned
16 Mar 2026
Nuno S. Fernandes President, APUS
Sold at will
$350.13K 6,500 at 53.87
7.2%
Not planned
16 Mar 2026
Rifat Kerim Akgonul Chief Product Officer
Sold at will
$329.50K 7,594 at 43.39
6.4%
Not planned
16 Mar 2026
Joseph L Hurley Chief Supply Chain Officer
Sold at will
$316.02K 3,910 at 80.82
11.9%
Not planned
16 Mar 2026
Sarah Fenton EVP Upstream
Sold at will
$314.45K 4,876 at 64.49
8.4%
Not planned
16 Mar 2026
Joana Goncalves Chief Medical Officer
Sold on a plan 4×
$312.56K 7,641 at 40.91
18.6%
Planned (10b5-1)
16 Mar 2026
Kim Coffin SVP, Chief Forager
Sold at will
$304.38K 3,766 at 80.82
13.5%
Not planned
16 Mar 2026
Timmi Zalatoris Chief Human Resources Officer
Sold at will
$296.46K 3,668 at 80.82
13.2%
Not planned
16 Mar 2026
Mervin Smith EVP Strategic Business Ops
Sold on a plan
$295.47K 2,585 at 114.30
10.1%
Planned (10b5-1)
16 Mar 2026
Joy Corso Chief Administrative Officer
Sold at will
$289.48K 49,484 at 5.85
3.9%
Not planned
16 Mar 2026
Nir Debbi President
Sold on a plan
$287.56K 8,332 at 34.51
0.2%
Planned (10b5-1)
16 Mar 2026
Brian Andrew Moriarty SVP - Corporate Communications
Sold at will
$282.20K 5,000 at 56.44
26.7%
Not planned
16 Mar 2026
Elizabeth E Reed Chief Legal Officer and GC
Sold on a plan
$280.86K 10,000 at 28.09
8.7%
Planned (10b5-1)
16 Mar 2026
Corey J Manley EVP&Chief Legal/Admin Officer
Sold on a plan
$256.88K 7,405 at 34.69
7.1%
Planned (10b5-1)
16 Mar 2026
Julie Rubinstein President and COO
Sold on a plan
$255.59K 19,060 at 13.41
3.6%
Planned (10b5-1)
16 Mar 2026
Stacy Rochelle Wright Chief Revenue Officer
Sold on a plan
$255.31K 13,750 at 18.57
12.5%
Planned (10b5-1)
16 Mar 2026
Marcus Becker SVP Cpo
Sold at will
$250.90K 10,000 at 25.09
26.9%
Not planned
16 Mar 2026
Ryan Cohlhepp President and COO
Sold on a plan 2×
$245.71K 12,500 at 19.66
5.9%
Planned (10b5-1)
16 Mar 2026
Mark N Rogers EVP & General Counsel
Sold on a plan
$222.70K 5,000 at 44.54
11.4%
Planned (10b5-1)
16 Mar 2026
Suzanne L Helen Possible Member of Group · indirect
Sold at will 3×
$206.61K 2,000 at 103.31
3.3%
Not planned
16 Mar 2026
Matthew Paul Larson Chief Risk Officer
Sold on a plan
$202.50K 11,250 at 18.00
100%
Sold half or more
16 Mar 2026
Amitabh Misra Chief Technology Officer
Sold at will
$200.01K 34,189 at 5.85
3.4%
Not planned
16 Mar 2026
Andrew Micallef EVP, Chief Operations Officer
Sold on a plan
$194.58K 1,000 at 194.58
9.1%
Planned (10b5-1)
16 Mar 2026
Arun Pattabhiraman Chief Marketing Officer
Sold at will
$190.13K 32,500 at 5.85
6.3%
Not planned
16 Mar 2026
Andrew Ross Camden President
Sold on a plan
$178.76K 9,625 at 18.57
2.6%
Planned (10b5-1)
16 Mar 2026
Erick Wayne DeVinney Chief Innovation Officer
Sold at will
$171.46K 5,221 at 32.84
1.9%
Not planned
16 Mar 2026
Daniel J Bartlett Executive Vice President
Sold on a plan
$167.33K 1,325 at 126.29
0.2%
Planned (10b5-1)
16 Mar 2026
James R. Kasinger General Counsel and Secretary
Sold at will
$166.50K 3,450 at 48.26
3.6%
Not planned
16 Mar 2026
Nick Caldwell V. Chief Product Officer
Sold at will
$164.77K 42,632 at 3.86
4.6%
Not planned
16 Mar 2026
Jay Sharp Executive Vice President
Sold on a plan 4×
$159.97K 2,000 at 79.99
2.5%
Planned (10b5-1)
16 Mar 2026
Mark Romaine Chief Operating Officer
Sold at will
$158.67K 3,376 at 47.00
2.1%
Not planned
16 Mar 2026
Naimish Patel Chief Medical Officer
Sold at will
$152.02K 3,150 at 48.26
19.3%
Not planned
16 Mar 2026
Daniel J Gerritzen General Counsel and Secretary
Sold at will
$148.59K 8,614 at 17.25
5.4%
Not planned
16 Mar 2026
Joseph W Hauser Pres. Trauma & Def. Correction
Sold at will
$148.28K 8,596 at 17.25
4.2%
Not planned
16 Mar 2026
Kieran Brennan Senior Vice President
Sold at will
$147.24K 12,000 at 12.27
4.1%
Not planned
16 Mar 2026
Dyan Z. Wold VP, Controller and CAO
Sold on a plan
$146.79K 1,539 at 95.38
24.9%
Planned (10b5-1)
16 Mar 2026
Gregory A Odle President of Scoliosis
Sold at will
$145.47K 8,433 at 17.25
4.3%
Not planned
16 Mar 2026
Michael S Gross See Remarks · indirect
Bought
$145.25K 10,452 at 13.90
0.3%
16 Mar 2026
Marie Mendoza SVP & General Counsel
Sold on a plan 4×
$134.88K 1,516 at 88.97
2.2%
Planned (10b5-1)
Showing 13,651–13,700 of 22,785. ← Newer Page 274 of 456 Older →